Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells

Biochemical Pharmacology

Volumn 57, Issue 8, 1999, Pages 861-867

  Ferry, Katherine V ^a   Fink, Daniel ^b   Johnson, Steven W ^a   Nebel, Sibylle ^b   Hamilton, Thomas C ^a   Howell, Stephen B ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cisplatin; DNA mismatch repair; Drug resistance

Indexed keywords

CELL EXTRACT; CISPLATIN;

ARTICLE; BASE MISPAIRING; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA SYNTHESIS; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BASE PAIR MISMATCH; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA ADDUCTS; DNA LIGASES; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; HUMANS; TUMOR CELLS, CULTURED;

EID: 0033561772     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00366-9     Document Type: Article

References (26)

1. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem. 65:1996;101-133.
2. Anthoney D.A., McIlwrath A.J., Gallagher W.M., Edlin A.R., Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 56:1996;1374-1381.
3. Aebi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R., Boland C., Koi M., Fishel R., Howell S. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:1996;3087-3090.
4. Fink D., Zheng H., Nebel S., Norris P., Aebi S., Lin T., Nehme A., Christen R., Haas M., MacLeod C., Howell S. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57:1997;1841-1845.
5. Boyer J., Umar A., Risinger J., Lipford J., Kane M., Yin S., Barrett J., Kolodner R., Kunkel T. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 55:1995;6063-6070.
6. Koi M., Umar A., Chauhan D., Cherian S., Carethers J., Kunkel T., Boland C. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 54:1994;4308-4312.
7. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehme A., Christen R., Howell S. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56:1996;4881-4886.
8. Umar A., Koi M., Risinger J., Glaab W., Tindall K., Kolodner R., Boland C., Barrett J., Kunkel T. Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine-resistance and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 57:1997;3949-3955.
9. Mello J., Acharya S., Fishel R., Essigmann J. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol. 3:1996;579-589.
10. 4-methylthymine, or the cisplatin-d(GpG) adduct. Proc Natl Acad Sci USA. 93:1996;6443-6447.
11. Yamada M., O'Regan E., Brown R., Karran P. Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. Nucleic Acids Res. 25:1997;491-495.
12. Mellon I., Champe G. Products of DNA mismatch repair genes mutS and mutL are required for transcription-coupled nucleotide-excision repair of the lactose operon in Escherichia coli. Proc Natl Acad Sci USA. 93:1996;1292-1297.
13. Mellon I., Rajpal D., Koi M., Boland C., Champe G. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science. 272:1996;557-560.
14. Hanawalt P.C., Donahue B.A., Sweder K.S. Repair and transcription: Collision or collusion? Curr Biol. 4:1994;518-521.
15. Manley J., Fire A., Cano A., Sharp P., Gefter M. DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract. Proc Natl Acad Sci USA. 77:1980;3855-3859.
16. Wood R.D., Robins P., Lindahl T. Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts. Cell. 53:1988;97-106.
17. Moggs J., Yarema K., Essigmann J., Wood R. Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct. J Biol Chem. 271:1996;7177-7186.
18. Zamble D., Mu D., Reardon J., Sancar A., Lippard S. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry. 35:1996;10004-10013.
19. Aboussekhra A., Biggerstaff M., Shivji M., Vilpo J., Moncollin V., Podust V., Protic M., Hubscher U., Egly J.-M., Wood R. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell. 80:1995;859-868.
20. Mu D., Park C., Matsunaga T., Hsu D., Reardon J., Sancar A. Reconstitution of human DNA repair excision nuclease in a highly defined system. J Biol Chem. 270:1995;2415-2418.
21. Mu D., Tursun M., Duckett D., Drummond J., Modrich P., Sancar A. Recognition and repair of compound lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol Cell Biol. 17:1997;760-769.
22. Moggs J., Szymkowski D., Yamada M., Karran P., Wood R. Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts. Nucleic Acids Res. 25:1997;480-490.
23. Fink D., Nebel S., Aebi S., Nehme A., Howell S. Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin. Int J Oncol. 11:1997;539-542.
24. Karran P., Bignami M. DNA damage tolerance, mismatch repair and genome instability. Bioessays. 16:1994;833-839.
25. Mamenta E., Poma E., Kaufmann W., Delmastro D., Grady H., Chaney S. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res. 54:1994;3500-3505.
26. Vaisman A., Varchenko M., Umar A., Kunkel T.A., Risinger J.I., Barrett J.C., Hamilton T.C., Chaney S.G. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts. Cancer Res. 58:1998;3579-3585.